Aurora Spine Corp (OTCPK:ASAPF)

$ 0.2995 0.0045 (1.53%) Market Cap: 22.62 Mil Enterprise Value: 25.44 Mil PE Ratio: 0 PB Ratio: 4.77 GF Score: 36/100

Q3 2024 Aurora Spine Corp Earnings Call Transcript
Oct 28, 2024

$0.29 (-14.68%)

Earnings
Q2 2024 Aurora Spine Corp Earnings Call Transcript
Aug 23, 2024

$0.19815 (-4.83%)

Earnings
Q4 2023 and Q1 2024 Aurora Spine Corp Combined Earnings call Transcript
May 14, 2024

$0.19506 (-2.96%)

Earnings
Q2 2023 Aurora Spine Corp Earnings Call Transcript
Aug 29, 2023

$0.2002 (+5.37%)

Earnings
Q1 2023 Aurora Spine Corp Earnings Call Transcript
May 24, 2023

$0.21 (-13.22%)

Earnings
Q4 2022 Aurora Spine Corp Earnings Call Transcript
May 01, 2023

$0.2193 (+2.00%)

Earnings
Aurora Spine Corp at Precious Metals Summit Planet Microcap Showcase Transcript
Apr 26, 2023
Aurora Spine Corp at Issuer Direct Planet MicroCap Showcase (Virtual) Transcript
Dec 07, 2022
Q3 2022 Aurora Spine Corp Earnings Call Transcript
Nov 21, 2022

$0.36755 (-4.18%)

Earnings
Aurora Spine Corp at Lytham Partners Spring Investor Conference (Virtual) Transcript
Apr 04, 2022
Aurora Spine Corp at Lytham Partners Winter Investor Conference (Virtual) Transcript
Dec 13, 2021
Q3 2021 Aurora Spine Corp Earnings Call Transcript
Nov 16, 2021

$0.29 (+1.40%)

Earnings
Aurora Spine Corp at Lytham Partners Fall Investor Conference (Virtual) Transcript
Oct 05, 2021

Aurora Spine Corp at Lytham Partners Spring Investor Conference (Virtual) Transcript

Apr 04, 2022 / 03:00PM GMT

Release Date Price: $0.352 (-4.86%)

Transcript

Adam Lowensteiner

Lytham Partners, LLC - Vice President

Hello, everyone, and welcome to the Lytham Partners Spring 2022 Investor Conference. My name is Adam Lowensteiner, Vice President of Lytham Partners. Thank you for joining us here today for a panel discussion hosted by Aurora Spine, titled, Simplifying the Complex -- A Panel Discussion with Doctors that use Aurora Spine Products.

We are joined by great doctors from different industry backgrounds to get some insights on how they use Aurora Spine and how they see the industry evolving. I've gathered some topics that are of interest to investors today and hope to learn greatly from our panelists.

Today, joining us are Trent Northcutt, CEO and Co-Founder of Aurora Spine; Dr. Michael Stoffman, a neurosurgeon in Buffalo, New York, and a clinical assistant professor in neurosurgery at Buffalo Neurosurgery State, University of New York; and Dr. Steven Falowski, a neurosurgeon at Advanced Surgery Center of Lancaster.

Before we begin with the discussion, I would like to have each of you introduce yourselves and provide a brief

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.